Jardiance helps adults following acute heart failure
Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance® (empagliflozin)
Source: eturbonews.com
Page 5 - Mohamed Eid News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mohamed Eid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mohamed Eid Today - Breaking & Trending Today
Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial
/PRNewswire/ -- Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance®...
Source: prnewswire.com
Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial
/PRNewswire/ -- Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance®...
Source: prnewswire.com
Clinical Benefit Seen With In-Hospital Initiation of Empagliflozin in Heart Failure Patients
Treatment with empagliflozin was shown to improve clinical outcomes in adults hospitalized for acute heart failure when initiated after stabilization and prior to discharge.
Source: empr.com
Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction
Indianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has approved Jardiance (empagliflozin) 10 mg to reduce the risk...
Source: medicaldialogues.in